SEC Form 4 · accession 0001209191-15-057094
Sesen Bio, Inc. · SESN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Abbie Celniker
Officer — President and CEO · Director
Period of report
Jun 26, 2015
Accepted (ET)
Jun 29, 2015 · 4:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001485003
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 26, 2015 | A | 85,800 | $0.00 | A | 440,130 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents restricted stock units which vest as to 33.33% of the original number of restricted stock units granted to Dr. Celniker on each of the six-month, twelve-month and eighteen-month anniversaries of the grant date.